» Articles » PMID: 22328081

Testosterone and Interleukin-1β Increase Cardiac Remodeling During Coxsackievirus B3 Myocarditis Via Serpin A 3n

Abstract

Myocarditis and dilated cardiomyopathy (DCM) are often caused by viral infections and occur more frequently in men than in women, but the reasons for the sex difference remain unclear. The aim of this study was to assess whether gene changes in the heart during coxsackievirus B3 (CVB3) myocarditis in male and female BALB/c mice predicted worse DCM in males. Although myocarditis (P = 4.2 × 10(-5)) and cardiac dilation (P = 0.008) were worse in males, there was no difference in viral replication in the heart. Fibrotic remodeling genes, such as tissue inhibitor of metalloproteinase (TIMP)-1 and serpin A 3n, were upregulated in males during myocarditis rather than during DCM. Using gonadectomy and testosterone replacement, we showed that testosterone increased cardiac TIMP-1 (P = 0.04), serpin A 3n (P = 0.007), and matrix metalloproteinase (MMP)-8 (P = 0.04) during myocarditis. Testosterone increased IL-1β levels in the heart (P = 0.02), a cytokine known to regulate cardiovascular remodeling, and IL-1β in turn increased cardiac serpin A 3n mRNA (P = 0.005). We found that 39 of 118 (33%) genes identified in acute DCM patients were significantly altered in the heart during CVB3 myocarditis in mice, including serpin A 3n (3.3-fold change, P = 0.0001). Recombinant serpin A 3n treatment induced cardiac fibrosis during CVB3 myocarditis (P = 0.0008) while decreasing MMP-3 (P = 0.04) and MMP-9 (P = 0.03) levels in the heart. Thus, serpin A 3n was identified as a gene associated with fibrotic cardiac remodeling and progression to DCM in male myocarditis patients and mice.

Citing Articles

Mitochondrial injury and complement dysregulation are drivers of pathological inflammation in viral myocarditis.

Mohamud Y, Bahreyni A, Hwang S, Lin J, Wang Z, Zhang J J Virol. 2025; 99(2):e0180424.

PMID: 39846741 PMC: 11852726. DOI: 10.1128/jvi.01804-24.


Therapeutic effects of platelet-derived extracellular vesicles on viral myocarditis correlate with biomolecular content.

Beetler D, Giresi P, Di Florio D, Fliess J, McCabe E, Watkins M Front Immunol. 2025; 15():1468969.

PMID: 39835120 PMC: 11743460. DOI: 10.3389/fimmu.2024.1468969.


Sex differences in mitochondrial gene expression during viral myocarditis.

Di Florio D, Weigel G, Gorelov D, McCabe E, Beetler D, Shapiro K Biol Sex Differ. 2024; 15(1):104.

PMID: 39696682 PMC: 11657264. DOI: 10.1186/s13293-024-00678-0.


Clinical features, myocardial injury and systolic impairment in acute myocarditis.

Shyam-Sundar V, Slabaugh G, Mohiddin S, Petersen S, Aung N Open Heart. 2024; 11(2.

PMID: 39627021 PMC: 11624809. DOI: 10.1136/openhrt-2024-002901.


Impact of Concurrent Ischaemic Stroke on Unfavourable Outcomes in Men and Women with Dilated Cardiomyopathy.

Fan Z, Wu C, Wang C, Liu C, Fang L, Ma L Rev Cardiovasc Med. 2024; 25(6):215.

PMID: 39076319 PMC: 11270057. DOI: 10.31083/j.rcm2506215.


References
1.
Regitz-Zagrosek V, Oertelt-Prigione S, Seeland U, Hetzer R . Sex and gender differences in myocardial hypertrophy and heart failure. Circ J. 2010; 74(7):1265-73. DOI: 10.1253/circj.cj-10-0196. View

2.
McNamara D, Starling R, Cooper L, Boehmer J, Mather P, Janosko K . Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study. J Am Coll Cardiol. 2011; 58(11):1112-8. PMC: 6467576. DOI: 10.1016/j.jacc.2011.05.033. View

3.
Morihara T, Teter B, Yang F, Lim G, Boudinot S, Boudinot F . Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models. Neuropsychopharmacology. 2005; 30(6):1111-20. DOI: 10.1038/sj.npp.1300668. View

4.
Yung C, Halperin V, Tomaselli G, Winslow R . Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. Genomics. 2004; 83(2):281-97. DOI: 10.1016/j.ygeno.2003.08.007. View

5.
Nikolic I, Liu D, Bell J, Collins J, Steenbergen C, Murphy E . Treatment with an estrogen receptor-beta-selective agonist is cardioprotective. J Mol Cell Cardiol. 2007; 42(4):769-80. DOI: 10.1016/j.yjmcc.2007.01.014. View